期刊文献+

慢性阻塞性肺疾病临床表型的研究进展 被引量:54

Research progress in clinical phenotypes of chronic obstructive pulmonary disease
下载PDF
导出
摘要 慢性阻塞性肺疾病(COPD)是一种气流受限不完全可逆的疾病,临床通常根据气流受限严重程度指导治疗。然而COPD患者在临床表现、疾病进展、治疗反应、肺功能下降程度及生活质量等方面存在显著差异。目前单一使用FEV1评估气流受限程度将COPD进行分类及作为疾病诊断、评估和治疗的手段,不能更好地反映COPD的异质性。近年来有学者试图通过不同的表型对COPD异质性进行描述和研究,认为COPD表型是未来研究的方向。本文就目前该方面的研究进展作一综述。 Chronic obstructive pulmonary disease (COPD) is a common respiratory disease defined as the presence of incomplete reversible air flow obstruction, and its treatment is mostly guided by the severity of this air flow obstruction. However, the traditional diagnosis, assessment and management of COPD are currently challenged. In recent years, it has widely been recognized that COPD is a complex syndrome characterized by numerous pulmonary and extrapulmonary manifestations. As for a method of diagnosis, evaluation, treatment and categorization of COPD, airflow obstruction alone isn't good enough for reflection of the heterogeneity of this disease. Some researchers reached a consensus on COPD, in which the importance of COPD phenotypes for the prevention and control of COPD were stressed. As the clinical phenotypes of COPD are still unclear and become a research focus, we summarized the recent research progress on COPD clinical phenotypes in this review.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2013年第6期519-523,共5页 Medical Journal of Chinese People's Liberation Army
关键词 慢性阻塞性肺疾病 表型 异质性 个体化治疗 chronic obstructive pulmonary disease phenotype heterogeneity individual therapy
  • 相关文献

参考文献33

  • 1蔡闯,叶钧强,何慕芝,毛荣华,钟南山.口服与静脉滴注左氧氟沙星治疗急性加重期中重度COPD的临床随机对照研究[J].解放军医学杂志,2010,35(12):1416-1419. 被引量:6
  • 2Burgel PR, Paillasseur JL, Tillie-Leblond I, et al. Clinical COPD phenotypes: a novelapproach using principal component andcluster analyses[J]. Eur Respir J, 2010, 36(3): 531-539.
  • 3Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD[J]. Am J Respir Crit Care Med, 2010, 182(5): 598-604.
  • 4Criner GJ, Sternberg AL. National Emphysema Treatment Trial: the maior outcomes of lung volume reduction surgery in severe emphysema[J]. Proc Am Thorac Soc, 2008, 5(4): 393-405.
  • 5Makita H. Annual decline of forced expiratory volume in 1 sec(FEV3)over 4 years in COPD based on clinical phenotypes[J]. AmJ Respir Crit Care Med, 2010, 181: A1834.
  • 6江汉,张巧,林科雄,赵志强,王金平,王长征.慢性阻塞性肺疾病与哮喘患者吸入支气管扩张剂后流速和容积反应的差异[J].解放军医学杂志,2009,34(8):940-944. 被引量:5
  • 7蔡柏蔷.放至全球而皆准的策略——我看《GOLD颁布的COPD全球策略(2011年修订版)》[J].中国实用内科杂志,2012,32(5):351-355. 被引量:64
  • 8Bon JM, Leader JK, Weissfeld, et al. The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease[J]. PLOS One, 2009, 4(8): e6865.
  • 9Anderson D, Macnee W. Targeted treatment in COPD: a multi- system approach for a multi-sytem disease[J]. Int J Chron Obustruct Pulmon Dis, 2009, 4: 321-335.
  • 10Mahler DA, Criner GJ. Assessment tools for chronic obstructive pulmonary disease:do newer metrics allow for disease modification[J] ? Proc Am Thorac Soc, 2007, 4(7): 507-511.

二级参考文献64

共引文献164

同被引文献454

引证文献54

二级引证文献525

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部